Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price.
October 29, 2018 at 16:53 PM EDT
The Foster City-based company said its generic versions of Harvoni, as well as Epclusa, will increase its market and reduce patient out-of-pocket expenses.
